Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
10
FDMT Quote, Financials, Valuation and Earnings
Last price:
$7.98
Seasonality move
:
0.56%
Day range:
$7.72 - $8.13
52-week range:
$2.24 - $12.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3,546.51x
P/B ratio:
1.23x
Volume:
763K
Avg. volume:
1M
1-year change:
37.18%
Market cap:
$455.4M
Revenue:
$37K
EPS (TTM):
-$3.94
Earnings Data
Next earnings date for FDMT
Feb 27
2026
Most recent earnings per share
-$1.01
Missed by $0.03
(Nov 10/2025)
Consensus Estimate
-$0.98
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FDMT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/27/2026 | Q4 | $30.9M | -- | -- | -$0.53 | -- |
| 11/10/2025 | Q3 | $403K | $90K | -$1.01 | -$0.98 | -$0.03 |
| 08/11/2025 | Q2 | $522.8K | $15K | -$0.98 | -$0.69 | -$0.28 |
| 05/08/2025 | Q1 | $446.3K | $14K | -$0.86 | -$0.86 | $0.00 |
| 02/28/2025 | Q4 | $2.3M | $1K | -$1.08 | -$0.84 | -$0.25 |
| 11/13/2024 | Q3 | $601.1K | $3K | -$0.79 | -$0.70 | -$0.08 |
| 08/08/2024 | Q2 | $685.7K | $5K | -$0.63 | -$0.71 | $0.08 |
| 05/09/2024 | Q1 | $915.7K | $28K | -$0.66 | -$0.76 | $0.10 |
| 02/29/2024 | Q4 | $2.4M | -- | -- | -$0.73 | -- |
| 11/09/2023 | Q3 | -- | $20.2M | -$0.24 | -- | -- |
| 08/09/2023 | Q2 | -- | $239K | -$0.77 | -- | -- |
| 05/10/2023 | Q1 | -- | $298K | -$0.88 | -- | -- |
| 03/15/2023 | Q4 | -- | $1.2M | -$0.84 | -- | -- |
| 11/08/2022 | Q3 | -- | $500K | -$0.79 | -- | -- |
| 08/11/2022 | Q2 | -- | $162K | -$0.87 | -- | -- |
| 05/12/2022 | Q1 | -- | $1.2M | -$0.82 | -- | -- |
| 03/28/2022 | Q4 | -- | $92K | -$0.85 | -- | -- |
| 11/10/2021 | Q3 | -- | $1.4M | -$0.82 | -- | -- |
| 08/12/2021 | Q2 | -- | $14.6M | -$0.28 | -- | -- |
| 05/13/2021 | Q1 | -- | $2M | -$0.61 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -$0.77 | -$0.66 | -$0.11 |
| 09/30/2020 | Q3 | -- | $7.4M | -$0.29 | -- | -- |
| 06/30/2020 | Q2 | -- | $3.6M | -$0.57 | -- | -- |
| 03/31/2020 | Q1 | -- | $3.5M | -$0.50 | -- | -- |
| 12/31/2019 | Q4 | -- | $2M | -$0.61 | -- | -- |
| 09/30/2019 | Q3 | -- | $540K | -$0.63 | -- | -- |
4D Molecular Therapeutics, Inc. Earnings Questions
-
How Much did 4D Molecular Therapeutics, Inc. Generate in Revenue Last Quarter?
4D Molecular Therapeutics, Inc. reported $90K worth of top line sales in its most recent quarter.
-
Did 4D Molecular Therapeutics, Inc. Beat Earnings Last Quarter?
4D Molecular Therapeutics, Inc. announced earnings per share of -$1.01 which represents a miss of analyst forecast a -$0.98 per share.
-
Is 4D Molecular Therapeutics, Inc. Profitable?
4D Molecular Therapeutics, Inc. reported -$1.9M that represents -$0.03 per share over the last quarter.
-
What is the Analyst Consensus for 4D Molecular Therapeutics, Inc. EPS Next Year?
4D Molecular Therapeutics, Inc.'s earnings are forecast to decrease from -$2.98 per share to -$3.26 per share next year representing a decrease of -9.27%.
-
When is 4D Molecular Therapeutics, Inc.'s Earnings Date?
4D Molecular Therapeutics, Inc.'s next earnings date is February 27, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
